Located in the Liverpool City Region, Speke manufactures an influenza vaccine in partnership with its sister site located in Philadelphia, USA. Around 400 employees comprised of scientists, manufacturing associates, engineers, quality professionals and support personnel form an integral part of AstraZeneca’s new Vaccine & Immune Therapy Area. It is the second largest Biologics site within the network, and a centre of excellence for testing and certification of medicines – supporting a further three additional commercial medicines. Speke is embarking on new and exciting ways to maximise learning and development, by advancing research, driving continuous improvement, and embracing digital by introducing collaborative robots and automation to our processes. Speke also focuses on community outreach supporting local charities where the biggest impact can be made, as well as fundraising, social events, and engaging children and young adults in STEM subjects.